Detalles de la búsqueda
1.
Oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza A virus.
J Virol
; 86(20): 10924-34, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22896605
2.
Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus.
Comp Immunol Microbiol Infect Dis
; 56: 6-13, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29406285
3.
Energy metabolic disorder is a major risk factor in severe influenza virus infection: Proposals for new therapeutic options based on animal model experiments.
Respir Investig
; 54(5): 312-9, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27566378
4.
Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenza.
PLoS One
; 9(5): e98032, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24865588
Resultados
1 -
4
de 4
1
Próxima >
>>